Companies
Neuralink
NeuralinkSan Francisco, CA
Founded 2016
Healthcare
Last Round Valuation
$9.65B
Last Round Share Price
$ XX.XY
Total Funding
$1.29B
Last Round
Series E
Neuralink
$77.61
1M
3M
YTD
1Y
2Y
MAX
Funding Rounds
Nothing here |
Information contained herein is based on estimates and is subject to update.
News
01/01/2026
Neuralink Begins High-Volume Production of Brain-Computer Interfaces
Neuralink's shift to high-volume production of brain-computer interfaces positions it to capture significant market share in neurotechnology, potentially enhancing profit margins and attracting investor interest as the sector evolves.
12/30/2025
Neuralink Raises $650 Million for Brain-Computer Interface Production
Neuralink's $650 million funding round underscores the escalating investor confidence in brain-computer interfaces, potentially revolutionizing healthcare and technology sectors while positioning the company as a leader in a rapidly emerging market.
12/10/2025
Neuralink Appoints FDA Executive to Enhance Medical Affairs
By appointing a former FDA executive, Neuralink aims to strengthen its regulatory strategy, potentially accelerating product development and enhancing investor confidence in its long-term growth prospects within the competitive neurotechnology market.
Research
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Are orders posted anonymously?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How can I get notified when there are new interested buyers of my shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How do Augment fees work?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
